Regulatory Peptides Journal

Overview
Identity
View All

publication venue for

NK2 ANTAGONISTS AND THE ROLE OF NK2 RECEPTORS 1992
SUBSTANCE-P AND OPIOID MECHANISMS IN ANTINOCICEPTION PRODUCED BY NOXIOUS CUTANEOUS STIMULATION IN THE RAT - A PHYSIOLOGICAL AND RECEPTOR-BINDING STUDY 1992
Structure and function of chemically specified enteric neurons in the guinea pig intestine 1992
Facilitation of the tail flick reflex by noxious thermal stimulation of the skin in the anaesthetized rat: Antagonism by a substance P analogue 1988
Intrathecal administration of substance P in the rat: Spinal transection or morphine blocks the vocalization or escape behaviour but not the facilitation of the tail flick reflex 1988
Luminal receptors for tachykinins on airway epithelia: Regional and interspecies variations 1988
SP responses on the canine colonic epithelium: Direct and indirect effects 1988
Neuropeptide content in rat hypothalami and their release from tissue 1982
Change in expression of vesicular protein synapsin II by chronic treatment with D2 allosteric modulator PAOPA. 66:58-62. 2015
The molecular characterization of the kinin transcript and the physiological effects of kinins in the blood-gorging insect, Rhodnius prolixus. 53:148-158. 2014
A comparison of host-defense peptides in skin secretions of female Xenopus laevis×Xenopus borealis and X. borealis×X. laevis F1 hybrids. 45:1-8. 2013
Preclinical pharmacokinetic and toxicological evaluation of MIF-1 peptidomimetic, PAOPA: Examining the pharmacology of a selective dopamine D2 receptor allosteric modulator for the treatment of schizophrenia. 42:89-96. 2013
Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. 35:86-94. 2012
Characterization of a long-acting recombinant human serum albumin-atrial natriuretic factor (ANF) expressed in Pichia pastoris. 175:7-10. 2012
Investigation of the potential involvement of eicosanoid metabolites in anti-diuretic hormone signaling in Rhodnius prolixus. 34:127-134. 2012
MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats. 28:2009-2015. 2007
A gastrin-releasing peptide receptor antagonist blocks d-amphetamine-induced hyperlocomotion and increases hippocampal NGF and BDNF levels in rats. 28:1447-1452. 2007
Neural and hormonal control of muscular activity of the spermatheca in the locust, Locusta migratoria. 28:174-184. 2007
The presence and distribution of crustacean cardioactive peptide in the central and peripheral nervous system of the stick insect, Baculum extradentatum. 129:191-201. 2005
Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: A model of human tardive dyskinesia. 24:313-319. 2003
PLG regulates hnRNP-L expression in the rat striatum and pre-frontal cortex: identification by ddPCR. 24:137-146. 2003
Acceleration of pubertal development following central blockade of the Y1 subtype of neuropeptide Y receptors. 95:47-52. 2000
l-Prolyl-l-leucyl-glycinamide and its peptidomimetic analog 3(R)-[(2(S)-pyrrolidylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide (PAOPA) attenuate haloperidol-induced c-fos expression in the striatum☆. 21:301-308. 2000
Modulatory effects of PLG and its peptidomimetics on haloperidol-induced catalepsy in rats. 20:761-767. 1999
Protection Against MPTP Treatment by an Analog of Pro-Leu-Gly-NH2 (PLG, MIF-1). 19:403-406. 1998
Colocalization of Inhibitory Mediators, NO, VIP and Galanin, in Canine Enteric Nerves. 19:99-112. 1998
Modulation of Dopamine Receptor Agonist-Induced Rotational Behavior in 6-OHDA-Lesioned Rats by a Peptidomimetic Analogue of Pro-Leu-Gly-NH2 (PLG). 18:1209-1215. 1997
Peptide YY stimulates circular muscle contractions of the isolated perfused canine ileum by inhibiting nitric oxide release and enhancing acetylcholine release. 14:1171-1178. 1993
Effects of bradykinin on the canine proximal colon. 46:511-522. 1993
Mechanism of noncholinergic excitation of canine ileal circular muscle by motilin. 12:1047-1050. 1991
Stimulation of circular muscle motility of the isolated perfused canine ileum: Relationship to VIP output. 12:1039-1045. 1991
Immunomodulatory activities of the somatostatin analogue BIM 23014c: effects on murine lymphocyte proliferation and natural killer activity. 32:129-139. 1991
β-Endorphin in pituitary intraglandular colloid of intermediate lobe origin. 12:25-29. 1991
Luminal responses to bradykinin on the isolated canine tracheal epithelium: effects of bradykinin antagonists. 30:221-230. 1990
Luminal receptors for bradykinin on the canine tracheal epithelium: functional subtyping. 21:237-244. 1988
Adrenocorticotropic hormone (ACTH) in pituitary colloid and extrapituitary tissues. 9:77-81. 1988
17β Estradiol-induced increase in brain dopamine D-2 receptor: Antagonism by MIF-1. 8:997-1002. 1987
Effects of unilateral intracerebroventricular microinjections of cholecystokinin (CCK) on circling behavior of rats. 8:989-995. 1987
Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG). 8:855-861. 1987
Luminal tachykinin receptors on canine tracheal epithelium: functional subtyping. 18:101-108. 1987
Distribution of label after intrathecal administration of 125I-substance P in the rat. 8:213-221. 1987
Target size analysis of neurotensin receptors. 8:195-197. 1987
Covalent labeling of neurotensin receptors in rat gastric fundus plasma membranes. 6:1137-1141. 1985
Effects of tachykinins on the electrical activity of isolated canine tracheal epithelium: an exploratory study. 12:9-19. 1985
Mesolimbic and striatal dopamine receptor supersensitivity: Prophylactic and reversal effects of L-prolyl-L-leucyl-glycinamide (PLG). 6:179-183. 1985
Characterization of neurotensin binding to rat gastric smooth muscle receptor sites. 5:917-923. 1984
Inhibition of satiety by a cholecystokinin antagonist is independent of gastric emptying. 5:481-484. 1984
Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindings. 2:105-111. 1981

has subject area

11 Medical and Health Sciences (FoR)
Endocrinology & Metabolism (Science Metrix)